Congress funds overdose data infrastructure, not opioid industry relief
H.R. 1257 — OPIOIDS Act · Filed by Laurel Lee (R-FL) · 2 cosponsors · Introduced Feb 12, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill authorizes the Attorney General to award grants to states, localities, and law enforcement agencies to improve data collection and surveillance on opioid overdoses, including funding for postmortem toxicology testing, forensic lab upgrades, officer training, and medical examiner resources. It also requires the DEA to establish uniform reporting standards for drug purity and formulation data, and mandates that grant recipients report overdose data to a national database.
Why we flagged it
The bill's operative mechanism is grant funding for overdose surveillance, forensic capacity, and law enforcement training — all directed at improving public data and law enforcement response to the opioid crisis. The named pharmaceutical companies in the mapped stocks reflect regulatory exposure (potential liability or compliance costs), not direct beneficiary status.
What the text implies
- Mandatory reporting requirement may create pressure on state/local labs to comply with federal standards, potentially shifting local autonomy over data systems to federal oversight.
- Uniform DEA reporting standards for drug purity and formulation could enable more precise tracking of drug supply chains, potentially increasing criminal prosecution capacity but also raising privacy concerns for individuals in overdose investigations.
- Grant funding is discretionary (Attorney General 'may' award, not 'shall'), creating uncertainty about actual implementation and geographic equity in overdose data collection.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill funds public health infrastructure (overdose data collection, forensic lab capacity, officer training) that directly serves public safety and evidence-based response to the opioid crisis. No private entities are shielded from liability, no public funds are diverted to private profit, and the mandatory reporting requirement increases transparency and accountability in overdose tracking.
Who stands to gain
- state and local law enforcement agencies
- forensic laboratories
- medical examiners and coroners offices
- Federal Law Enforcement Training Centers
Named in the bill
Attorney General, Drug Enforcement Administration (DEA), National Forensic Laboratory Information System, Federal Law Enforcement Training Centers, Office of National Drug Control Policy, Omnibus Crime Control and Safe Streets Act of 1968, Fentanyl Signature Profiling Program
Where it stands
2 cosponsors: 2 Democrats.
- Feb 12, 2025 — Introduced · Congress.gov: “Introduced in House”
- Feb 12, 2025 — Referred to House Committee on the Judiciary · Congress.gov: “Referred to the House Committee on the Judiciary”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (2,836 characters) on Aug 13, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress funds overdose data infrastructure, not opioid industry relief” QuorumCivic. https://share.quorumcivic.app/bill/119/hr1257 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.